Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

ABC Survey - do we Meet the Needs of Patients With Advanced Breast Cancer?

This study has been completed.
Information provided by (Responsible Party):
Cancer Trials Ireland Identifier:
First received: January 24, 2014
Last updated: March 27, 2015
Last verified: March 2015
The study will follow a descriptive design involving a survey. Data collection will involve paper based questionnaires. The questionnaires have been developed in conjunction with breast cancer support groups associated with the Irish Cancer Society and patients.

Metastatic Breast Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: ABC Survey: Are we Meeting the Needs of Patients With Advanced Breast Cancer (ABC) in Ireland? A Nationwide Survey

Resource links provided by NLM:

Further study details as provided by Cancer Trials Ireland:

Primary Outcome Measures:
  • Needs of MBC patients in Ireland [ Time Frame: Following analysis of the questionnaires completed by the patients, estimated 24 months ]
    The needs of MBC patients to be identified and categorised with particular focus on; quality of life, symptom burden and access to and value of available support

Secondary Outcome Measures:
  • Future service developments [ Time Frame: Following analysis of the questionnaires completed by patients, estimated 24 months ]
    Evaluation of future service developments that will provide support to these patients

Enrollment: 500
Study Start Date: May 2013
Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)
Metastatic Breast Cancer

Detailed Description:

The purpose of the study is to identify and categorise the need of Metastatic Breast Cancer (MBC) patients in Ireland with particular focus on; quality of life, symptom burden and access to and value of support available.

The study also aims to evaluate future service developments that will provide support to these patients.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients must have metastatic breast cancer

Inclusion Criteria:

  • Signed written informed consent
  • Clinical diagnosis of MBC
  • Female aged 18 years or older
  • Able to complete the questionnaires independently

Exclusion Criteria:

  • Any patient who does not meet the above mentioned inclusion criteria.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT02051010

Bon Secours Hospital
Cork, Ireland
Cork University Hospital
Cork, Ireland
South Infirmary - Victoria University Hospital
Cork, Ireland
Letterkenny General Hospital
Donegal, Ireland
Saint Vincent Universtiy Hospital
Dublin, Ireland, 4
Mater Misericordiae University Hospital and Mater Private Hospital
Dublin, Ireland, 7
Saint James's Hospital
Dublin, Ireland, 8
Beaumont Hospital
Dublin, Ireland
Galway University Hospital
Galway, Ireland
Kerry General Hospital
Kerry, Ireland
Midwestern Regional Hospital
Limerick, Ireland
Sligo General Hospital
Sligo, Ireland
Waterford Regional Hospital
Waterford, Ireland
Sponsors and Collaborators
Cancer Trials Ireland
  More Information

Responsible Party: Cancer Trials Ireland Identifier: NCT02051010     History of Changes
Other Study ID Numbers: ICORG 13-01
Study First Received: January 24, 2014
Last Updated: March 27, 2015

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases processed this record on May 23, 2017